AtriCure, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)
AtriCure, Inc. (ATRC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) of $275.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-10-31.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease · last filed 2014-10-31
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2014-09-30 was $151.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2014-06-30 was $19.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2014-03-31 was $105.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2013-12-31 was -$204.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for fiscal 2012 was $179.00K, a 678.26% increase from fiscal 2011.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for fiscal 2011 was $23.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $170.00K derived: sum of 2 quarters · filed 2014-10-31 | $275.00K 10-Q · filed 2014-10-31 | $71.00K derived: sum of 4 quarters · filed 2014-10-31 |
| 2014-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $124.00K 10-Q · filed 2014-07-30 | -$80.00K derived: sum of 3 quarters · filed 2014-10-31 | -$106.00K derived: sum of 4 quarters · filed 2014-10-31 |
| 2014-03-31 | $105.00K 10-Q · filed 2014-04-30 | -$99.00K derived: sum of 2 quarters · filed 2014-10-31 | -$125.00K derived: sum of 3 quarters · filed 2014-10-31 | -$153.00K derived: sum of 4 quarters · filed 2014-10-31 |
| 2013-12-31 | -$204.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-10-31 | -$230.00K derived: sum of 2 quarters · filed 2014-10-31 | -$258.00K derived: sum of 3 quarters · filed 2014-10-31 | -$272.00K 10-Q · filed 2014-10-31 |
| 2013-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$54.00K derived: sum of 2 quarters · filed 2013-11-01 | -$68.00K 10-Q · filed 2013-11-01 | |
| 2013-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$42.00K 10-Q · filed 2013-08-02 | ||
| 2013-03-31 | -$14.00K 10-Q · filed 2013-05-03 | |||
| 2012-12-31 | $179.00K 10-K · filed 2014-03-11 | |||
| 2011-12-31 | $23.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |